As expected, our findings revealed that even at exceedingly low doses (1 μm), IR‐LND effectively lowered the expression of TGF‐β in tumor cells (Figure 3A; Figures S16 and S17, Supporting Information). The gene discussed is TGFB1; the disease is neoplasm.